Skip to content

The Effect of Blue and Red LED Lights on Pimples on the Face

Effect of Blue and Red LEDs on Inflammatory Acne : controlled and randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4s35wkz
Enrollment
Unknown
Registered
2022-09-22
Start date
2022-05-09
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acne vulgaris

Interventions

This is a controlled, randomized, blinded, 4 arm study. The Group 1 will have 36 participants who will wear a mask with blue LEDs at a wavelength of 415 nm (plus or minus 20 nm), 3 times a week for 12
E02.594.540

Sponsors

Universidade Nove de Julho - UNINOVE
Lead Sponsor
Universidade Nove de Julho - UNINOVE
Collaborator

Eligibility

Age
12 Years to 25 Years

Inclusion criteria

Inclusion criteria: People aged 12 to 25 years of either sex who have inflammatory acne grades 2 and 3.People who do not have any disease that interferes with the worsening of acne. During the anamnesis if there is any disease the pictures will be discussed with the dermatologist.

Exclusion criteria

Exclusion criteria: People with Fitzpatrick rating scale V and VI due to risk of post-inflammatory hyperpigmentation; People who have used oral medications such as isotretinoin in the last six months or antibiotics for acne in the last 3 months or who are using hormones;Pregnant or lactating women;Women using contraceptives;People who have used cosmetic acne treatments such as lasers and medium to deep peels in the last 3 months.People allergic to salicylic acid

Design outcomes

Primary

MeasureTime frame
The appearance and reduction of lesions will be verified through clinical analysis of the photos, verifying the reduction of erythema and general appearance of the skin.

Secondary

MeasureTime frame
The degree of patient satisfaction will be evaluated through a questionnaire given to the participant at the end of the treatment.

Countries

Brazil

Contacts

Public ContactLara Motta

Universidade Nove de Julho - UNINOVE

larajmotta@uni9.pro.br+55(11)33859241

Outcome results

None listed

Source: REBEC (via WHO ICTRP)